TrialX Updates: Unveiling AI-Powered Enhancements in TrialX’s Patient Recruitment Solution at the 12th Annual Patients as Partners Conference
We’re proud to be executive sponsors of the 12th Annual Patients as Partners in Clinical Research conference! Visit us at booth # 13 and catch our Co-founder & CEO, Sharib Khan, on The View panel discussion along with leaders from Parexel, Heartbeat Clinical Research, BioMarin Pharmaceutical Inc. and The Black Breast Cancer Alliance. 
Topic: Enhancing Patient Engagement Through AI – Insights & Experiences
Date: March 18, 2025
Time: 11:45 AM EST
If you’re attending the conference, don’t miss this insightful session! Schedule a meeting with us to learn more.
What’s New at TrialX! 
️ SCOPE 2025 – KEY TAKEAWAYS
At the 16th Annual SCOPE Summit 2025, over 4,000 clinical research professionals, thought leaders, and innovators from 1,200+ organizations gathered to explore key topics such as AI, patient-centricity, digital health, and diversity and inclusion in clinical trials. Representing TrialX, Chief Strategy Officer Paul Donnelly and Senior Director of Client Services Wes Martz showcased how our cutting-edge solutions are transforming the industry. We were proud to highlight AI-driven enhancements to our award-winning enterprise patient recruitment solution and advancements in our remote data collection platform. Read Highlights.
PRODUCT UPDATES
Our improved patient recruitment system now lets study teams create campaigns tailored to specific countries and languages. Study admins can set these preferences, ensuring participants are directed to the right study pages. A trackable URL automatically adjusts to include the correct country and language parameters.
RECENT CURETALKS 
Take a deep dive into the world of Fibrodysplasia ossificans progressiva (FOP) with leading experts Dr. Frederick S. Kaplan and Dr. Mona Al Mukaddam from University of Pennsylvania and patient advocate Whitney Weldon. FOP is an ultra-rare disease affecting about 1 in 2 million people worldwide. Caused by an ACVR1 gene mutation, it disrupts bone regulation, turning soft tissue into bone. Even minor injuries can trigger rapid bone growth, severely limiting mobility and quality of life. With no cure, FOP presents significant challenges for patients and medical professionals. Watch here.
FEATURED CLINICAL STUDIES
Powered by TrialX
The ABLE Project: Indiana University researchers are conducting The Adjustment, Behavior, Language and Executive Functioning (ABLE) Project to study how preschool children’s thinking and behavior skills impact social and emotional development. They are recruiting children aged 3 to 6 who use cochlear implants or have normal hearing, with spoken English as their primary language.
Tranquillo 2: Researchers are studying whether a once-daily oral medication may be effective in treating nonsegmental vitiligo. The clinical trial is recruiting adults 18+ who have had nonsegmental vitiligo for at least three months, with vitiligo on the face and body, whether active or stable. If eligible, participants will help advance potential treatment options for vitiligo worldwide.
Sleep-dependent Learning in Aging: Researchers at the University of Massachusetts are studying how sleep impacts memory changes with aging. The study examines whether differences in sleep and memory contribute to age-related cognitive changes. Participants aged 18-75 will take part in experiments involving sleep, wakefulness, and memory tasks, with neuroimaging used to analyze brain activity.
INSIGHT Study: Researchers at Penn Medicine are looking for participants for a virtual, paid research study to learn more about how health information is perceived on the social media platform TikTok. You may be eligible if you are 18-35 years old and use social media regularly.
AROUND THE WEB
Anti-aging breakthrough? Controversial supplements target ‘zombie’ cells.
AI mind reader: New model predicts schizophrenia and bipolar progression. Moon boot camp: How jumping could prep astronauts for Mars.
First-of-its-kind drug slashes risk of heart attacks and strokes.
NOTEWORTHY
TEAM UPDATES
WELCOMING NEW MEMBERS
Eric Sandor joins us as Executive Chairman, bringing 30+ years of leadership in Health and Life Sciences. A pioneer in business transformation, he has deep expertise in strategy, operations, technology, and organizational restructuring. Passionate about innovation, he drives AI-enabled solutions, high-performing teams, and unlocking potential in people and companies.
Monica Zhang joins TrialX as a Service Manager for our patient recruitment management system in Dallas, US. Originally from China, she brings expertise in software implementation and project delivery, ensuring technology empowers teams and clients. An artist at heart, she published her first illustration at age 8 and enjoys gardening, painting, and traveling.
Molly Pacheco joins us as a Solution Specialist for our patient recruitment management system. Originally from Florida, she has a Psychology background and 6+ years in EHR, fueling her passion for healthcare technology. A writer and storyteller, she enjoys creating worlds and playing Dungeons & Dragons with her husband and friends. She is A lifelong cat lover with a soft spot for dogs.
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to streamline patient recruitment and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!
All the best,
Team TrialX
